|
1
|
Huang D, Refaat M, Mohammedi K, Jayyousi
A, Al Suwaidi J and Abi Khalil C: Macrovascular complications in
patients with diabetes and prediabetes. Biomed Res Int 2017.
78391012017.
|
|
2
|
Kaur R, Kaur M and Singh J: Endothelial
dysfunction and platelet hyperactivity in type 2 diabetes mellitus:
Molecular insights and therapeutic strategies. Cardiovasc Diabetol.
17:1212018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galley HF and Webster NR: Physiology of
the endothelium. Br J Anaesth. 93:105–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Q, Zhang M, Ding Y, Wang Q, Zhang W,
Song P and Zou MH: Activation of NAD(P)H oxidase by
tryptophan-derived 3-hydroxykynurenine accelerates endothelial
apoptosis and dysfunction in vivo. Circ Res. 114:480–492. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hotamisligil GS: Inflammation and
metabolic disorders. Nature. 444:860–867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donath MY: Targeting inflammation in the
treatment of type 2 diabetes: Time to start. Nat Rev Drug Discov.
13:465–476. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan SF, Ramasamy R, Naka Y and Schmidt AM:
Glycation, inflammation, and RAGE: A scaffold for the macrovascular
complications of diabetes and beyond. Circ Res. 93:1159–1169. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haidari M, Zhang W, Willerson JT and Dixon
RA: Disruption of endothelial adherens junctions by high glucose is
mediated by protein kinase C-beta-dependent vascular endothelial
cadherin tyrosine phosphorylation. Cardiovasc Diabetol. 13:1052014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sajja RK, Prasad S and Cucullo L: Impact
of altered glycaemia on blood-brain barrier endothelium: An in
vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS.
11:82014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao XY, Wang XF, Li L, Zhang L, Shen DL,
Li DH, Jin QS and Zhang JY: Effects of high glucose on human
umbilical vein endothelial cell permeability and myosin light chain
phosphorylation. Diabetol Metab Syndr. 7:982015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen G, Chen Y, Chen H, Li L, Yao J, Jiang
Q, Lin X, Wen J and Lin L: The effect of NF-kappaB pathway on
proliferation and apoptosis of human umbilical vein endothelial
cells induced by intermittent high glucose. Mol Cell Biochem.
347:127–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kageyama S, Yokoo H, Tomita K,
Kageyama-Yahara N, Uchimido R, Matsuda N, Yamamoto S and Hattori Y:
High glucose-induced apoptosis in human coronary artery endothelial
cells involves up-regulation of death receptors. Cardiovas
Diabetol. 10:732011. View Article : Google Scholar
|
|
13
|
Ning RB, Zhu J, Chai DJ, Xu CS, Xie H, Lin
XY, Zeng JZ and Lin JX: RXR agonists inhibit high glucose-induced
upregulation of inflammation by suppressing activation of the NADPH
oxidase-nuclear factor-kappaB pathway in human endothelial cells.
Genet Mol Res. 12:6692–6707. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Owen GR, Achilonu I and Dirr HW: High
yield purification of JNK1beta1 and activation by in vitro
reconstitution of the MEKK1-->MKK4-->JNK MAPK phosphorylation
cascade. Protein Expr Purif. 87:87–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ip YT and Davis RJ: Signal transduction by
the c-Jun N-terminal kinase (JNK)-from inflammation to development.
Curr Opin Cell Biol. 10:205–219. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Newton K and Dixit VM: Signaling in innate
immunity and inflammation. Cold Spring Harb Perspect Biol. 4(pii):
a0060492012.PubMed/NCBI
|
|
17
|
Foletta VC, Segal DH and Cohen DR:
Transcriptional regulation in the immune system: All roads lead to
AP-1. J Leukoc Biol. 63:139–152. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kralisch S, Sommer G, Stangl V, Köhler U,
Kratzsch J, Stepan H, Faber R, Schubert A, Lössner U, Vietzke A, et
al: Secretory products from human adipocytes impair endothelial
function via nuclear factor kappaB. Atherosclerosis. 196:523–531.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen C, Li Q, Zhang YC, Ma G, Feng Y, Zhu
Q, Dai Q, Chen Z, Yao Y, Chen L, et al: Advanced glycation
endproducts increase EPC apoptosis and decrease nitric oxide
release via MAPK pathways. Biomed Pharmacother. 64:35–43. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamawaki H, Saito K, Okada M and Hara Y:
Methylglyoxal mediates vascular inflammation via JNK and p38 in
human endothelial cells. Am J Physiol Cell Physiol.
295:C1510–C1517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Breton-Romero R, Feng B, Holbrook M, Farb
MG, Fetterman JL, Linder EA, Berk BD, Masaki N, Weisbrod RM,
Inagaki E, et al: Endothelial dysfunction in human diabetes is
mediated by Wnt5a-JNK signaling. Arterioscler Thromb Vasc Biol.
36:561–569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sabio G and Davis RJ: TNF and MAP kinase
signalling pathways. Semin Immunol. 26:237–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dhanasekaran DN and Reddy EP:
JNK-signaling: A multiplexing hub in programmed cell death. Genes
Cancer. 8:682–694. 2017.PubMed/NCBI
|
|
24
|
Li L, Hou X, Xu R, Liu C and Tu M:
Research review on the pharmacological effects of astragaloside IV.
Fundam Clin Pharmacol. 31:17–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
You LZ, Lin YX, Fang ZH, Shen GM, Zhao JD
and Wang TT: Research advances on astragaloside-IV in treatment of
diabetes mellitus and its complications pharmacological effects.
Zhongguo Zhong Yao Za Zhi. 42:4700–4706. 2017.(In Chinese).
PubMed/NCBI
|
|
26
|
Yin Y, Qi F, Song Z, Zhang B and Teng J:
Ferulic acid combined with astragaloside IV protects against
vascular endothelial dysfunction in diabetic rats. Biosci Trends.
8:217–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang WJ and Frei B: Astragaloside IV
inhibits NF-κB activation and inflammatory gene expression in
LPS-treated mice. Mediators Inflamm 2015. 2743142015.
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhong W, Zou G, Gu J and Zhang J:
L-arginine attenuates high glucose-accelerated senescence in human
umbilical vein endothelial cells. Diabetes Res Clin Pract.
89:38–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng
TI, Wu HY and Liu SH: Inhibition of NADPH oxidase-related oxidative
stress-triggered signaling by honokiol suppresses high
glucose-induced human endothelial cell apoptosis. Free Radic Biol
Med. 44:2043–2050. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Campos C: Chronic hyperglycemia and
glucose toxicity: Pathology and clinical sequelae. Postgrad Med.
124:90–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ceriello A: Point: Postprandial glucose
levels are a clinically important treatment target. Diabetes Care.
33:1905–1907. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grassi D, Desideri G, Necozione S,
Ruggieri F, Blumberg JB, Stornello M and Ferri C: Protective
effects of flavanol-rich dark chocolate on endothelial function and
wave reflection during acute hyperglycemia. Hypertension.
60:827–832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jourdan T, Godlewski G, Cinar R, Bertola
A, Szanda G, Liu J, Tam J, Han T, Mukhopadhyay B, Skarulis MC, et
al: Activation of the Nlrp3 inflammasome in infiltrating
macrophages by endocannabinoids mediates beta cell loss in type 2
diabetes. Nat Med. 19:1132–1140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Masters SL, Dunne A, Subramanian SL, Hull
RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen
Z, et al: Activation of the NLRP3 inflammasome by islet amyloid
polypeptide provides a mechanism for enhanced IL-1β in type 2
diabetes. Nat Immunol. 11:897–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei X, Song H, Yin L, Rizzo MG, Sidhu R,
Covey DF, Ory DS and Semenkovich CF: Fatty acid synthesis
configures the plasma membrane for inflammation in diabetes.
Nature. 539:294–298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang W, Wang WH, Azadzoi KM, Dai P, Wang
Q, Sun JB, Zhang WT, Shu Y, Yang JH and Yan Z: Alu RNA accumulation
in hyperglycemia augments oxidative stress and impairs eNOS and
SOD2 expression in endothelial cells. Mol Cell Endocrinol.
426:91–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang X, Wu Z and He Y, Zhang H, Tian L,
Zheng C, Shang T, Zhu Q, Li D and He Y: Humanin prevents high
glucose-induced monocyte adhesion to endothelial cells by targeting
KLF2. Mol Immunol. 101:245–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang WJ, Hufnagl P, Binder BR and Wojta
J: Antiinflammatory activity of astragaloside IV is mediated by
inhibition of NF-kappaB activation and adhesion molecule
expression. Thromb Haemost. 90:904–914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gui D, Huang J, Guo Y, Chen J, Chen Y,
Xiao W, Liu X and Wang N: Astragaloside IV ameliorates renal injury
in streptozotocin-induced diabetic rats through inhibiting
NF-κB-mediated inflammatory genes expression. Cytokine. 61:970–977.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li HB, Ge YK, Zhang L and Zheng XX:
Astragaloside IV improved barrier dysfunction induced by acute high
glucose in human umbilical vein endothelial cells. Life Sci.
79:1186–1193. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lo HM, Lai TH, Li CH and Wu WB: TNF-α
induces CXCL1 chemokine expression and release in human vascular
endothelial cells in vitro via two distinct signaling pathways.
Acta Pharmacol Sin. 35:339–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hattori K, Naguro I, Runchel C and Ichijo
H: The roles of ASK family proteins in stress responses and
diseases. Cell Commun Signal. 7:92009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yokoi T, Fukuo K, Yasuda O, Hotta M,
Miyazaki J, Takemura Y, Kawamoto H, Ichijo H and Ogihara T:
Apoptosis signal-regulating kinase 1 mediates cellular senescence
induced by high glucose in endothelial cells. Diabetes.
55:1660–1665. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shin M, Yan C and Boyd D: An inhibitor of
c-jun aminoterminal kinase (SP600125) represses c-Jun activation,
DNA-binding and PMA-inducible 92-kDa type IV collagenase
expression. Biochim Biophys Acta 1589. 311–316. 2002.
|
|
46
|
Zhu W, Yuan Y, Liao G, Li L, Liu J, Chen
Y, Zhang J, Cheng J and Lu Y: Mesenchymal stem cells ameliorate
hyperglycemia-induced endothelial injury through modulation of
mitophagy. Cell Death Dis. 9:8372018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tournier C: Requirement of JNK for
stress-induced activation of the cytochrome c-mediated death
pathway. Science. 288:870–874. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chauhan D, Li G, Hideshima T, Podar K,
Mitsiades C, Mitsiades N, Munshi N, Kharbanda S and Anderson KC:
JNK-dependent release of mitochondrial protein, Smac, during
apoptosis in multiple myeloma (MM) cells. J Biol Chem.
278:17593–17596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim BJ, Ryu SW and Song BJ: JNK- and p38
kinase-mediated phosphorylation of Bax leads to its activation and
mitochondrial translocation and to apoptosis of human hepatoma
HepG2 cells. J Biol Chem. 281:21256–21265. 2006. View Article : Google Scholar : PubMed/NCBI
|
